Neuropace, Inc. · NASDAQ:NPCE
Becker Joel had 1,126 Neuropace, Inc. shares withheld for tax (Form 4)
Traded Aug 27, 2026 · Filed Aug 28, 2026
On Aug 27, 2026, Becker Joel (Director, CHIEF EXECUTIVE OFFICER) had 1,126 Neuropace, Inc. shares withheld for tax at US$14.13 for US$15,910, leaving 139,310 shares. Filed Aug 28, 2026 (Form 4).
- Withheld for tax
- 1,126 shares
- Price
- US$14.13
- Value
- US$15,910
- Holding after
- 139,310 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Common Stock | Shares withheld for tax | 1,126 | US$14.13 | 139,310 | Direct |
Source
Related
- Neuropace, Inc.
- Becker Joel
- Neuropace, Inc. shareholders
- Form 4 · Becker Joel · Sep 4, 2026
- Form 4 · Becker Joel · Jun 4, 2026
- Form 4 · Becker Joel · May 28, 2026
- Form 4 · Becker Joel · May 19, 2026
- Form 4 · Morrell Martha · Sep 25, 2026
- Form 4 · Williams Patrick F. · Sep 21, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Sep 4, 2026
- Form 4 · Morrell Martha · Aug 28, 2026
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026